General Information of the Compound
Compound ID
CP0272176
Compound Name
N-[4-(6-methyl-1,3-benzothiazol-2-yl)phenyl]-1-(thiophene-2-sulfonyl)piperidine-4-carboxamide
    Show/Hide
Synonyms
Benzothiazole analog 3
PMID26815044-Compound-38
    Show/Hide
Structure
Formula
C24H23N3O3S3
Molecular Weight
497.667
Canonical SMILES
Cc1ccc2nc(sc2c1)-c1ccc(NC(=O)C2CCN(CC2)S(=O)(=O)c2cccs2)cc1
    Show/Hide
InChI
InChI=1S/C24H23N3O3S3/c1-16-4-9-20-21(15-16)32-24(26-20)18-5-7-19(8-6-18)25-23(28)17-10-12-27(13-11-17)33(29,30)22-3-2-14-31-22/h2-9,14-15,17H,10-13H2,1H3,(H,25,28)
    Show/Hide
InChIKey
IVGKSFUEBSXSAE-UHFFFAOYSA-N
Physicochemical Property
logP
5.37262
Rotatable Bonds
5
Heavy Atom Count
33
Polar Areas
79.37
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
6
Complexity
33

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 1190414
ChEMBL ID
CHEMBL460340
Clinical Information about the Compound
Drug 1 ( Benzothiazole analog 3 )
Drug Name Benzothiazole analog 3
Indication
Albinism
Patented
Ephelides
Patented
Menkes disease
Patented
Senile lentigines
Patented
Melasma
Patented
Target(s)
Tyrosinase (TYR)
Inhibitor